Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International Inc. has announced that its Board of Directors will meet on March 6, 2025, to approve and publish the annual financial results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment. A conference call is scheduled on the same day to discuss the financial results, which suggests an effort to maintain transparent communication with its stakeholders and could impact investor confidence and stock market positioning.
More about JD Health International, Inc.
JD Health International Inc. is a company incorporated in the Cayman Islands with limited liability, focusing on health-related services and products. It operates within the healthcare industry, providing a range of health management solutions and pharmaceutical products, primarily in the Chinese market.
YTD Price Performance: 25.44%
Average Trading Volume: 11,680,196
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$114.3B
For detailed information about 6618 stock, go to TipRanks’ Stock Analysis page.
